{"id":"NCT01657292","sponsor":"Birken AG","briefTitle":"Oleogel-S10 Versus Standard of Care in Healing of Grade 2a Burn Wounds","officialTitle":"Open, Blindly Evaluated, Prospective, Controlled, Randomized, Multicenter Phase III Clinical Trial to Compare Intra-individually the Efficacy and Tolerance of Oleogel-S10 Versus Standard of Care in Accelerating the Healing of Grade 2a Partial-Thickness Burn Wounds","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-08","primaryCompletion":"2013-07","completion":"2014-07","firstPosted":"2012-08-06","resultsPosted":"2015-09-28","lastUpdate":"2015-09-28"},"enrollment":61,"design":{"allocation":"RANDOMIZED","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Burns"],"interventions":[{"type":"DRUG","name":"Oleogel-S10 ointment","otherNames":[]},{"type":"DEVICE","name":"Octenilin® wound gel","otherNames":["Contains Octenidine"]}],"arms":[{"label":"Oleogel-S10 ointment","type":"EXPERIMENTAL"},{"label":"Octenilin® wound gel","type":"OTHER"}],"summary":"The main goal of this phase III clinical trial is to show safety and efficacy of Oleogel-S10 in the acceleration of wound healing of grade 2a burn wounds.","primaryOutcome":{"measure":"Percentage of Patients With Earlier Healing of the Wound Half Treated With Oleogel-S10 Compared to the Wound Half Receiving Standard of Care","timeFrame":"2 to 3 weeks","effectByArm":[{"arm":"Entire Study Population","deltaMin":85.7,"sd":null}],"pValues":[{"comp":"OG000","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":13},"locations":{"siteCount":9,"countries":["Germany","Sweden","Switzerland","United Kingdom"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":61},"commonTop":[]}}